MindMed
MindMed is a neuropharmaceutical company that discovers, develops, and deploys psychedelic inspired medicines to improve health, promote wellness, and alleviate suffering. The company's approach is to use psychedelic substances in a controlled, therapeutic context.
History[edit | edit source]
MindMed was founded in 2019 by JR Rahn and Stephen Hurst, two entrepreneurs with a background in the technology industry. The company was established with the aim of developing psychedelic-inspired medicines. MindMed became the first psychedelic pharmaceutical company to be listed on the NASDAQ in April 2021.
Research and Development[edit | edit source]
MindMed's research and development efforts are focused on the therapeutic potential of psychedelic substances such as LSD, MDMA, DMT, and psilocybin. The company is conducting clinical trials to investigate the potential of these substances to treat a variety of mental health conditions, including anxiety, depression, and addiction.
Clinical Trials[edit | edit source]
MindMed is currently conducting multiple Phase II clinical trials to evaluate the safety and efficacy of its psychedelic-inspired medicines. These trials are being conducted in accordance with the guidelines established by the Food and Drug Administration (FDA) and other regulatory bodies.
Partnerships[edit | edit source]
MindMed has established partnerships with several academic institutions, including the University Hospital Basel's Liechti Lab in Switzerland, to conduct research on psychedelic substances. The company is also collaborating with the Digital Medicine division of the University Hospital Basel to develop a digital therapeutic platform for psychedelic therapies.
Criticism and Controversy[edit | edit source]
Despite the potential therapeutic benefits of psychedelic substances, their use in medicine has been controversial due to their association with recreational drug use and potential for abuse. However, MindMed and other companies in the psychedelic medicine space argue that these substances can be used safely and effectively in a controlled, therapeutic context.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
